Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tryp Therapeutics Inc (TRYP.CN)

Tryp Therapeutics Inc (TRYP.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 5,785
  • Shares Outstanding, K 96,419
  • Annual Sales, $ 0 K
  • Annual Income, $ -5,267 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -1.60
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings $-0.01 on 02/05/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0250 +140.00%
on 04/10/24
0.0650 -7.69%
on 04/26/24
+0.0350 (+140.00%)
since 04/01/24
3-Month
0.0100 +500.00%
on 03/05/24
0.0650 -7.69%
on 04/26/24
+0.0200 (+50.00%)
since 02/01/24
52-Week
0.0100 +500.00%
on 03/05/24
0.1100 -45.45%
on 09/11/23
-0.0300 (-33.33%)
since 05/01/23

Most Recent Stories

More News
Tryp Therapeutics Files Amended Financial Statements for the Six Months Ended February 29, 2024

Kelowna, British Columbia--(Newsfile Corp. - May 17, 2024) - Tryp Therapeutics, Inc. (CSE: TRYP) ("Tryp" or the "Company") announces, that it has filed amended financial statements for the six months ended...

TRYP.CN : 0.0600 (unch)
Markets Head into Christmas with Sparse Economic Lineup

Monday U.S. Economic Lookahead NAHB Home Builders Index (Dec.) Featured Earnings HEICO ...

TRYP.CN : 0.0600 (unch)
SCS : 16.14 (+0.12%)
TTC : 90.01 (+0.57%)
PHA.VN : 0.025 (unch)
MU : 391.00 (+0.49%)
NKE : 65.83 (+0.64%)
HEI : 343.60 (-1.19%)
CCL : 28.83 (+2.05%)
NDA.VN : 0.980 (-2.00%)
GIS : 44.51 (+1.21%)
PAYX : 107.57 (+0.35%)
KMX : 47.81 (-1.93%)
Sen. Cory Booker Pushing for Psychedelics Treatment of Mental Health

The psychedelic story is coming back strong. All after Sen. Cory Booker tweeted, “Massive breakthroughs in medical studies with psilocybin and MDMA are showing strong promise for patients with PTSD,...

TRYP.CN : 0.0600 (unch)
CMPS : 7.22 (+3.14%)
FTHW.VN : 0.055 (-8.33%)
SILFF : 0.0112 (+53.42%)
TRYPF : 0.0562 (+32.24%)
FTHWF : 0.0412 (-8.44%)
SILO.CN : 0.0100 (unch)
CYBN : 8.28 (+1.22%)
Stocks in play: Tryp Therapeutics Inc

Today announced the filing of two new provisional patent applications. One patent application, #63/405,786, ...

TRYP.CN : 0.0600 (unch)
TRYP THERAPEUTICS INC. ANNOUNCES CLOSING OF THIRD TRANCHE OF PRIVATE PLACEMENT

/CNW/ -- Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) ("Tryp" or the "Company"), a clinical-stage biotechnology company focused on developing psilocybin-based...

TRYP.CN : 0.0600 (unch)
TRYPF : 0.0562 (+32.24%)
Stocks in play: Tryp Therapeutics Inc

Announced a non-brokered private placement to its co-Founder and Executive Director, William J. Garner, ...

TRYP.CN : 0.0600 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Tryp Therapeutics Inc is a clinical-stage biotechnology company focused on developing psilocybin-related molecules, for the treatment of diseases with unmet medical needs. Tryp's program is focused on the development of synthetic psilocybin-related molecules as a new class of drug for the treatment of...

See More

Key Turning Points

3rd Resistance Point 0.0600
2nd Resistance Point 0.0600
1st Resistance Point 0.0600
Last Price 0.0600
1st Support Level 0.0600
2nd Support Level 0.0600
3rd Support Level 0.0600

See More

52-Week High 0.1100
Fibonacci 61.8% 0.0718
Fibonacci 50% 0.0600
Last Price 0.0600
Fibonacci 38.2% 0.0482
52-Week Low 0.0100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar